Dynamics of blood cytokine concentrations in patients with bacteremic infections

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 4, 1996, Pages 391-398

  Kragsbjerg, Peter ^a,b   Holmberg, Hans ^a   Vikerfors, Tomas ^a  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b Sonderborg Hospital   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOOD LEVEL; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; SEPSIS; SEPTIC SHOCK;

EID: 0029836491     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609037926     Document Type: Article

References (31)

1. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack van Schijndel RJM, Eerenberg AJM, Thijs LG, Aarden LA. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704-1710, 1989.
2. Calandra T, Baumgartner J-D, Grau GE, Wu M-M, Lambert P-H, Schellekens J, Verhoef J, Glauser MP, the Swiss-Dutch J5 Immunoglobulin Group. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 161: 982-987, 1990.
3. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis and human IL-6 as a marker of severity. Ann Surg 215: 356-362, 1992.
4. Hack CE, Hart M, Strack van Schijndel RJM, Eerenberg AJM, Nuijens JH, Thijs LG, Aarden LA. Interleukin-8 in sepsis: relation to shcok and inflammatory mediators. Infect Immunol 60: 2835-2842, 1992.
5. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771-778, 1993.
6. Villers D, Dao T, Nguyen J-M, Bironneau E, Godard A, Moreau M, De Groote D, Nicolas F, Soulillou J-P, Anegon I. Increased plasma levels of human interleukin for DA1.a cells/ leukemia inhibitor factor in sepsis correlate with shock and poor prognosis. J Infect Dis 171: 232-236, 1995.
7. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355-357, 1987.
8. Waring PM, Waring LJ, Metcalf D. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. J Infect Dis 170: 1224-1228, 1994.
9. Riesenfeld-Örn I, Wolpe S, Garcia-Bustos JF, Hoffmann MK, Tuomanen E. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun 57: 1890-1893, 1989.
10. Bayston K, Tomlinson M, Cohen J. In-vitro stimulation of TNF-α from human whole blood by cell-free supernatants of gram-positive bacteria. Cytokine 4:397-402, 1992.
11. Houldsworth S, Andrew PW, Mitchell TJ. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1β by human mononuclear phagocytes. Infect Immun 62: 1501-1503, 1994.
12. Norrby A, Norgren M, Holm SE. Elevated levels of interleukin 6 in serum of patients with serious group A streptococcal infections. Infection 20: 369-370, 1992.
13. Söderquist B, Sundqvist KG, Vikerfors T. Kinetics of interleukin-6, tumor necrosis factor-α and interleukin-1β in patients with Staphylococcus aureus septicemia. Immunol Infect Dis 4: 235-242, 1994.
14. Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Correlation between serum TNF-α and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis 27: 125-130, 1995.
15. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, Murray JF. Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141: 94-97, 1990.
16. Cebon J, Layton JE, Maher D, Morstyn G. Endogenous haematopoietic growth factors in neutropenia and infection. Br J Haematol 86: 265-274, 1994.
17. Bone RC. Gram-negative sepsis: A dilemma of modern medicine. Clin Microbiol Rev 6: 57-68, 1993.
18. Debets JMH, Kampmeijer R, van der Linden MPMH, Buurman WA, van der Linden CJ. Plasma tumor necrosis factor and mortality in critically ill patients. Crit Care Med 17: 489-494, 1989.
19. Offner F, Phillippé J, Vogelaers D, Colardyn F, Baele G, Baudrihave M, Vermeulen A, Leroux-Roels G. Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 116: 100-105, 1990.
20. Gårdlund B, Sjölin J, Nilsson A, Roll M, Wickerts C-J, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 172: 296-301, 1995.
21. Engervall P, Granström M, Andersson B, Björkholm M. Monitoring of endotoxin, interleukin-6, and C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol 54: 226-234, 1995.
22. Pauksens K, Elfman L, Ulfgren A-K, Venge P. Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 88: 256-260, 1994.
23. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, Baker JB. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 88: 1362-1369, 1991.
24. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62: 2715-2721, 1994.
25. Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun 59: 4614-4620, 1991.
26. Hackett SP, Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β synthesis. J Infect Dis 168: 232-235, 1993.
27. Norrby-Teglund A, Norgren M, Holm SE, Andersson U, Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun 62: 3731-3738, 1994.
28. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90: 2031-2037, 1992.
29. Mayer P, Geissler K, Ward M, Metcalf D. Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 81: 3226-3233, 1993.
30. Prins JM, Kuijper E, Mevissen MLCM, Speelman P, van Deventer SJH. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun 63: 2236-2242, 1995.
31. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 172: 886-891, 1995.